A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

  • days left to enroll
  • participants needed
  • sponsor
    Addpharma Inc.
Updated on 24 March 2022


The purpose of this study is to evaluate the efficacy and safety of AD-221 and AD-221A


The purpose of this study is to evaluate the efficacy and safety of AD-221 and AD-221A in patients with primary hypercholesterolemia

Condition Primary Hypercholesterolemia
Treatment AD-221, AD-221A, AD-221B, AD-221C
Clinical Study IdentifierNCT05131997
SponsorAddpharma Inc.
Last Modified on24 March 2022


Yes No Not Sure

Inclusion Criteria

Signed informed consent
Subjects with primary hypercholesterolemia

Exclusion Criteria

Patient with secondary dyslipidemia
Other exclusions applied
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note